TherapeuticsMD Announces Third Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
TherapeuticsMD (TXMD) Tops Q3 EPS by 5c
November 7, 2018 4:53 PM ESTTherapeuticsMD (NASDAQ: TXMD) reported Q3 EPS of ($0.16), $0.05 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $3.5 million versus the consensus estimate of $4.43 million.
For earnings history and earnings-related data on TherapeuticsMD (TXMD) click here.
... More